Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy

Introduction: In Japan, adjuvant tegafur-uracil (UFT) chemotherapy is recommended for patients with completely resected, stage I NSCLC. This treatment requires real-world re-evaluation because of recent advances in target-based and immuno-oncological treatments and refinement of lung cancer staging....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Takehito Shukuya, MD, PhD, Kazuya Takamochi, MD, PhD, Hiroyuki Sakurai, MD, PhD, Kiyotaka Yoh, MD, Tomoyuki Hishida, MD, PhD, Masahiro Tsuboi, MD, PhD, Yasushi Goto, MD, PhD, Yujin Kudo, MD, PhD, Yasuhisa Ohde, MD, PhD, Sakae Okumura, MD, Masataka Taguri, PhD, Hideo Kunitoh, MD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-05-01
coleção:	JTO Clinical and Research Reports
Assuntos:	Non–small cell lung cancer Adjuvant chemotherapy Randomized clinical trial Real-world study Tegafur-uracil
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666364322000443
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!